Podcasts about type1

To have your question featured in a future video, please visit: DrMorses.TV/ask Buy herbs: https://jo.my/handcrafted-formulas Getting Started Guide: https://jo.my/start-here-hbf

They said GLPs weren't for type one. Then Lilly enrolled 905 people. Here's what the research actually shows, and the part about your settings nobody's talking about. twiist - A different type of insulin pump has arrived ABLEnow save for today's needs or invest for tomorrow Eversense CGM MiniMed Tandem Mobi ** Use code JUICEBOX to save 20% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!  

Lauri Beale never imagined a routine visit would end with her 5-year-old daughter being diagnosed with type 1 diabetes. What followed was an 11-month honeymoon phase that left her family in a constant state of uncertainty. While her daughter was still producing some insulin, every day felt unpredictable, and Lauri found herself waiting for the other shoe to drop.In this conversation with Risely's Director of Coaching, Abby Cooper, Lauri shares what the first year after diagnosis really looked like. From the mental load that consumed every conversation with her husband to learning how to parent as a team without letting diabetes take over their family, she opens up about the challenges most parents don't expect. She also shares how expanding her toolkit through coaching, prioritizing her own mental health, and reframing blood sugar data helped her move from fear to confidence. If you're raising a child with type 1 diabetes and wondering whether life will ever feel manageable again, this episode offers practical hope from someone who's been there.WHAT WE COVER:What an 11-month honeymoon phase practically looked like with insulin dosing The simple communication rule that stopped diabetes from taking over every conversation in their marriageThe three things that helped Lauri stop living in survival mode after her daughter's diagnosisThe biggest frustrations with their endocrinology appointments, and how they got the confidence to stop waiting in between appointments to make changesHow they started building diabetes independence in their 6-year-old without putting too much on her shouldersThe mindset and management changes that helped increase their daughter Regan's Time in Range from 65% to 85%WHAT'S NEXT:

Guest Full Name: Dr. David-Alexandre (“DA”) C. Gros, MD CEODA's Bio:Dr. Gros has served as Chief Executive Officer and a member of the Board of Directors of Eledon Pharmaceuticals, Inc. since September 2020. He joined Eledon Pharmaceuticals from Imbria Pharmaceuticals Inc., where he served as Co-Founder, Chief Executive Officer and Chairman of the Board of Directors. Prior to Imbria, Dr. Gros was President and Chief Operating Officer of Neurocrine Biosciences, Inc., Chief Business and Principal Financial Officer of Alnylam Pharmaceuticals, Inc., and Chief Strategy Officer of Sanofi, S.A. Before joining Sanofi, Dr. Gros held leadership positions in healthcare investment banking at Centerview Partners, LLC, and Merrill Lynch, Pierce, Fenner & Smith Inc., and in healthcare consulting at McKinsey & Company. He previously served on the Board of Directors of Eliem Therapeutics, Inc., a biotechnology company which he co-founded, and is currently the Executive Chairman of Saint Jean Groupe, S.A., a leading French manufacturer of pasta products since 1935.Dr. Gros earned his Doctor of Medicine from The Johns Hopkins University School of Medicine, a Master of Business Administration from Harvard Business School, and a Bachelor of Arts from Dartmouth College.Company: Eledon Pharmaceuticals, Inc.Ticker: ELDNWebsite: https://eledon.com/About the Company:Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company that is developing immune-modulating therapies for the management and treatment of life-threatening conditions. The Company's lead investigational product is tegoprubart, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential. The central role of CD40L signaling in both adaptive and innate immune cell activation and function positions it as an attractive target for non-lymphocyte depleting, immunomodulatory therapeutic intervention. The Company is building upon a deep historical knowledge of anti-CD40 Ligand biology to conduct preclinical and clinical studies in kidney allograft transplantation, xenotransplantation, islet cell transplantation, and amyotrophic lateral sclerosis (ALS). Eledon is headquartered in Irvine, California.

 From 75% to 92% Time in Range! Jared's story is a powerful reminder that you don't have to settle for unpredictable blood sugars or feel like diabetes is controlling your life.With the right knowledge, tools, and consistent effort, you can learn to understand your numbers—and thrive with diabetes instead of just managing it. Watch Jared's story and see what's possible! >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

In this episode, we sit down with Dennis Goldensohn who has lived with Type 1 Diabetes for 58 years. From the era of boiling glass syringes and urine tests to today's connected insulin pumps and continuous glucose monitors, Dennis shares how diabetes management evolved from guesswork into a science. We also discuss the importance of mindset, surviving the day to day and how to build habits that became second nature. We talk about the discipline it took to keep showing up, and the advice he'd give anyone newly diagnosed today. Along the way, he reflects on refusing to let the diagnosis define his identity, choosing instead to see it as a circumstance he manages rather than a label he wears. This conversation is packed with practical wisdom on longevity, mindset, and what it really means to thrive — not just survive — with Type 1 Diabetes for nearly six decades.   Join the Diapoint mailing list for exclusive insights, offers and diabetes wisdom. If you're enjoying this podcast, we'd love to hear from you! Your feedback helps us create content that serves you better. So, if you have a moment, please head over to Apple Podcasts—or wherever you listen to your podcasts—and give us a rating and review. Five-star ratings really help us reach more listeners. Don't forget to hit that 'Subscribe' button so you never miss an episode. And, if any of our episodes or guests resonate with you, share them on social media or forward them to friends and family who would benefit from our community's collective wisdom. Visit the D-Shop where we offer beautiful, practical diabetes supplies and lifestyle accessories. The Ultimate T1D Game Plan: A game-changing home study program for parents of school-aged children with Type 1 Diabetes. Diabetes resources. Are you a healthcare provider or coach who wishes to coach your clients or have more meaningful conversations with your diabetes patients? Check out How to Coach People With Diabetes at www.diapointlearning.com Looking for health support? Set up a FREE Health Plan call today! Book a time to meet with Pam at this link. Watch our podcast episodes and more on our YouTube Channel! @DiapointTV   Connect with Diapoint @diapointme: Instagram | Facebook | Twitter | Pinterest Connect with Diapoint Arabia: Instagram | Facebook | DiapointArabia.com Find episodes, show notes and guest info of all Dia-Logue episodes on the Diapoint website. Would you like to sponsor our podcast? Get in touch: info@diapointme.com Diapoint is the place for people touched by diabetes. For more information and full details of our work, visit diapointme.com . Subscribe to the podcast so you get notifications for all our episodes, and please share it on social media or with anyone you think could benefit from this free content. Thank you for listening!

Un journal de brèves "Dans les pantoufles de Darwin" : la vie privée étonnante de Charles Darwin Un Dino dans les étoiles: au-delà de nos planètes Comment faire du sport quand on vit avec un diabète de type 1?

Graham asked Ken one question that stopped him in his tracks - is there a right or wrong way to manage Type 1 diabetes? The wrong way to manage Type 1 diabetes has nothing to do with your numbers. Nothing to do with your A1C, your TIR, pre-bolusing, carb counting, or CGM numbers. For Ken, the one non-negotiable your mental health. Because if your mental health isn't in alignment with your diabetes, none of the other stuff works the way it should. Fear, resentment, burnout, avoidance - will run your decisions and move you towards distrust in yourself. 

American Diabetes AssociationEmail the show at kids@mpbonline.orgHost: Dr. Morgan McLeod, Asst. Professor of Pediatrics and Internal Medicine at the University of Mississippi Medical Center.If you enjoyed listening to this podcast, please consider contributing to MPB: https://donate.mpbfoundation.org/mspb/podcast Hosted on Acast. See acast.com/privacy for more information.

In this episode, Dr. Samira Shafaee shares how her family's experience with type 1 diabetes inspired the creation of the T1D Oral Health Foundation. She discusses the unique oral health challenges associated with T1D, common misconceptions within dentistry, and why greater education is needed to better support patients and families.  Episode highlights: Why oral health is often overlooked in type 1 diabetes care Common misconceptions dentists have about caring for patients with T1D The daily realities and challenges of living with type 1 diabetes How treating hypoglycemia with sugar affects oral health The mission of the T1D Oral Health Foundation to improve education and awareness Ready to thrive as a dentist and a mom? Join a supportive community of like-minded professionals at Mommy Dentists in Business. Whether you're looking to grow your practice, find balance, or connect with others who understand your journey, MDIB is here to help. Visit mommydibs.com to learn more and become a part of this empowering network today!

Pam Durant talks about preparing for and managing diabetes at school with Sara Adhami, Dubai Based Certified Diabetes Educator & Accredited Practicing Dietician. Sara walks us through what should be in a Diabetes Medical Management Plan, and how to navigate food and carb counting while at school.   Join the Diapoint mailing list for exclusive insights, offers and diabetes wisdom. Visit the D-Shop where we offer beautiful, practical diabetes supplies and lifestyle accessories. The Ultimate T1D Game Plan: A game-changing home study program for parents of school-aged children with Type 1 Diabetes. Check out our Diabetes resources. Are you a healthcare provider or coach who wishes to coach your clients or have more meaningful conversations with your diabetes patients? Check out How to Coach People With Diabetes at www.diapointlearning.com Looking for health support? Set up a FREE Health Plan call today! Book a time to meet with Pam at this link. Watch our podcast episodes and more on our YouTube Channel! @DiapointTV Connect with Diapoint @diapointme: Instagram | Facebook | Twitter | Pinterest Connect with Diapoint Arabia: Instagram | Facebook | DiapointArabia.com Find episodes, show notes and guest info of all Dia-Logue episodes on the Diapoint website. Would you like to sponsor our podcast? Get in touch: info@diapointme.com Diapoint is the place for people touched by diabetes. For more information and full details of our work, visit diapointme.com . Subscribe to the podcast so you get notifications for all our episodes, and please share it on social media or with anyone you think could benefit from this free content. Thank you for listening!

In this episode, Dr. Steve Edelman and Dr. Jeremy Pettus are joined by Dr. Shara Bialo, Senior Medical Director of Type 1 Diabetes Immunology at Sanofi, pediatric endocrinologist, and person living with type 1 diabetes, for an in-depth discussion about what happens before type 1 diabetes is diagnosed. Together, they explore the autoimmune process that begins months or even years before symptoms appear, why early detection matters, and how screening is changing the future of type 1 diabetes care. Dr. Bialo shares her personal diagnosis story, discusses common misconceptions about what causes type 1 diabetes, and explains the three stages of the disease. The conversation also covers who should be screened, how diabetes autoantibody testing works, the benefits of preserving beta cell function, and why identifying people before they develop symptoms can lead to better long-term outcomes and fewer cases of diabetic ketoacidosis (DKA). Whether you have type 1 diabetes, have a family member at risk, or simply want to better understand the latest advances in prevention and early detection, this episode provides valuable insights into one of the fastest-moving areas of diabetes research.Key Topics:Dr. Shara Bialo's personal journey living with type 1 diabetesWhy type 1 diabetes is an autoimmune disease, not simply a blood sugar problemThe role of genetics, viral infections, and the immune systemUnderstanding the three stages of type 1 diabetesWhy most people diagnosed with type 1 diabetes have no family historyAdult-onset type 1 diabetes and why it is often mistaken for type 2 diabetesWhat diabetes autoantibodies are and how screening worksWho should consider screening for type 1 diabetesAvailable screening options, including blood tests and home screening kitsThe emotional challenges families face when considering screeningThe importance of preventing diabetic ketoacidosis through early detectionWhy preserving beta cell function can improve long-term outcomesItaly's national screening program and the future of population-wide screeningResources available through screenfortype1.comThis content was produced with support from Sanofi and screenfortype1.com.✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

 Real progress isn't about perfection—it's about consistency.- A1C: 7.4 → 6.7- Time in Range: 62% → 80%More importantly? More confidence, fewer lows, and the freedom to enjoy life again.Small, sustainable changes really do add up. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

This week on the podcast, I chat. with Maariesya aka Blonde and Blue Collar. We chat about her original plan to go to flight school that was grounded due to her Type 1 diabetes. She talks about how she was turned onto carpentry shortly after when her uncle asked her if she wanted to help restore an old barn. We highlight the up's and down's of having type 1 while working blue collar.

Send a message to MeganListen in to this episode with Michelle, where she shares her experience with Hashimoto's, Celiac Disease, and raising a child with Type 1 Diabetes. You can find her on Instagram HEREIf you have driving anxiety and you want to watch a short free video on how to drive with ease and heal your driving anxiety click here 

When your child's CGM alarms at 2 a.m., does your body go into panic mode before your brain has a chance to think?If you're raising a child with Type 1 diabetes, you know the constant mental load. The carb counting, the overnight alarms, the second guessing, and the pressure to get every decision right.In this episode, Lauren and Risely's Director of Coaching, Abby Cooper, sit down after spending  three days at the Friends for Life Conference to share the seven things they wish every T1D caregiver knew. Not carb ratios or pump settings, but the beliefs, nervous system patterns, and relationship dynamics that quietly shape everything about how T1D feels to manage as a family. Including why shielding your child from the burden of this disease can work against them, why your nervous system matters just as much as their blood sugar, and why time and happiness deserves just as much weight as time in range.WHAT WE COVER:Highlights from the Orlando Friends for Life ConferenceThe surprising difference between teaching diabetes management and helping your child build a healthy relationship with diabetesWhy your child's nervous system often mirrors yours, and practical ways to stay regulated during stressful diabetes momentsThe mistake many parents make when trying to "protect" their child from diabetes, and how to build confidence through age-appropriate independenceHow diabetes quietly creates resentment between partners, and the conversation most couples never realize they need to haveWhy T1D Facebook groups can leave parents feeling more anxious than informed, and how to know when it's time to step awayWhy one family with 93% Time in Range still felt like they were losing, and the powerful concept of Time in Happiness that completely reframes success as a T1D caregiverWHAT'S NEXT:

High blood sugars don't happen for no reason.The key isn't guessing—it's understanding why they happen. Once you learn the patterns, your blood sugars become more predictable, and so does your confidence. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

In today's episode, we sit down with Dr. Jody Stanislaw to discuss the relationship between sugar, blood glucose, and Type 1 diabetes. Diagnosed with Type 1 diabetes at just seven years old, Dr. Stanislaw has spent more than four decades living with the condition and over a decade helping others better understand how to manage it. Now, she combines personal experience with professional expertise to offer a practical perspective on diabetes care that emphasizes education, lifestyle, and informed decision-making. Dr. Stanislaw is a naturopathic physician, Certified Diabetes Educator, Type 1 Diabetes Specialist, and founding board member of the Low Carb Diabetes Association. Through her virtual practice, she works with individuals around the world to improve blood sugar management while addressing the broader lifestyle factors that influence long-term health. Hit play to learn about: Common misconceptions about sugar and Type 1 diabetes. Practical strategies for improving blood sugar management. The role of nutrition in supporting metabolic health. Why lifestyle habits matter alongside insulin therapy. Dr. Stanislaw earned her Doctorate in Naturopathic Medicine in 2007 and has become a leading educator in the Type 1 diabetes community. Her TEDx Talk, Sugar Is Not a Treat, has been viewed more than five million times, helping raise awareness about diabetes management and the impact of nutrition on overall health. Connect with Dr. Stanislaw: Personal Website Buy Hunger: An Adventurous Journey of Finding Peace Within Tedx Talk Facebook Instagram X Youtube

On this bonus episode of Diabetes Connections... we're talking about a fascinating new partnership between Omnipod and Calm – the meditation app, designed specifically for people with type 1 diabetes. Calm says it helps people sleep more, stress less and live mindful.. what does that look like for our community? I'm talking to advocate Meg Cremins, a Calm user who lives with type 1 and got to check out the collaboration, about what it sounds like, who it helps, and her thoughts on why caring for your mental health isn't really separate from diabetes care. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at Moms' Night Out this fall (and check out our 2027 cities)! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

I love when I get to learn from fellow Enneagram coaches and hear about their real-world experiences and fresh takes.In this episode, I had the opportunity to sit down with Lee Fields and Seth "Creek" Creekmore, co-founders of Analog Enneagram, to discuss the coworker chemistry between the Enneagram Type 1 (Striving to Feel Perfect) and Type 4 (Striving to Feel Unique).Lee is a certified Enneagram coach and teacher who serves as VP of the IEA Southeast chapter and on faculty with Awareness to Action. Creek is a coach, musician, and podcast producer behind Fathoms, the Awareness to Action Podcast, and the IEA's podcast. Together they bring serious depth to this framework, and honestly, this was one of the most thoughtful, insight-packed conversations I've had on the show.Lee represented the One, Creek represented the Four, and what unfolded was a refreshing, honest, funny, and real-life look at how these two types show up in working relationships and on teams; from the quiet trust-building in the beginning of a One-Four dynamic, to the friction points around identity and rigidity, to the surprising gifts each type brings when they're working well together.If you work with a One or a Four, lead one, or are one yourself, this episode will give you language for dynamics you've probably felt but never quite named.Connect with Lee & Creek:

Join Pam for this very important episode as she speaks with Farah Dahabi, a Clinical Social Worker and Director at LightHouse Arabia, who specializes in grief, trauma, and health psychology. During their discussion, they unpack the trauma a parent goes through when their child is diagnosed with Type 1 Diabetes. Farah also shares strategies to help caretakers cope with the stress and anxiety of managing a chronic condition like Type 1 Diabetes in a child.   Join the Diapoint mailing list for exclusive insights, offers and diabetes wisdom. You can also find free resources, blogs and articles about health, wellness, and diabetes at www.diapointme.com or visit the Diapoint Shop at www.diapointshop.com for beautiful diabetes and health accessories.   If you're enjoying this podcast, we'd love to hear from you! Your feedback helps us create content that serves you better. So, if you have a moment, please head over to Apple Podcasts— Spotify or wherever you listen to your podcasts—and give us a rating and review. Five-star ratings really help us reach more listeners.   Don't forget to hit the 'Subscribe' button so you never miss an episode. And if any of our episodes or guests resonate with you, share them on social media or forward them to friends and family who would benefit from our community's collective wisdom.   Visit the Diapoint Shop, where we offer beautiful, practical diabetes supplies and lifestyle accessories.   The Ultimate T1D Game Plan: A game-changing home study program for parents of school-aged children with Type 1 Diabetes.   Are you a healthcare provider or coach who wishes to coach your clients or have more meaningful conversations with your diabetes patients? Check out How to Coach People With Diabetes at www.diapointlearning.com   Diabetes resources.   Looking for health support? Set up a FREE Health Plan call today! Book a time to meet with Pam at this link.   You can also watch our podcast episodes and more on our YouTube Channel! @DiapointTV   Connect with Diapoint @diapointme: Instagram | Facebook | Twitter | Pinterest   Connect with Diapoint Arabia in Arabic: Instagram | Facebook | DiapointArabia.com   Find episodes, show notes, and guest info for all Dia-Logue episodes on the Diapoint website.   Would you like to sponsor our podcast? Get in touch: info@diapointme.com   For more information and full details of our work, visit diapointme.com. Subscribe to the podcast so you get notifications for all our episodes, and please share it on social media or with anyone you think could benefit from this free content. Thank you for listening!

We get into the emotional side of raising a child with type 1 diabetes: the pressure to be perfect, the guilt that social media can create, and the way so many parents slowly lose themselves after diagnosis without even realizing it. We do "check-ins" at our mom's night Out events where you can ask any question of a diabetes expert. I thought it would be helpful to bring those questions and answers to you here. My guest is Abby Cooper, mom of a child with T1D and Risely Health diabetes coach.. who was one of our check in experts this year. We talk about independence, middle school, camp, and what happens when your entire identity starts revolving around your child's diagnosis. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Join us at Mom's Night Out this fall in Detroit and Seattle. Use promo code FFL to save (valid until 7/19) Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

What can 21 days of continuous glucose and ketone data, recorded during a 1,000-mile cycling journey, reveal about managing type 1 diabetes on a ketogenic diet?Dr. Ian Lake is a UK-based primary care physician who has lived with type 1 diabetes for more than 30 years. After two decades of conventional high-carbohydrate management, he adopted a very low-carbohydrate, ketogenic approach and began examining insulin not simply as a glucose-lowering medication, but as a metabolic hormone whose requirements are influenced by nutrition, exercise, sleep, circadian rhythm, hydration, and stress. His new book, Shifting Gears, documents the ride and the lessons he took from it.Dr. Lake treated the journey as a 21-day personal experiment, wearing continuous glucose and ketone monitors while consuming roughly 20 grams of carbohydrate per day. In this conversation with Dr. Dominic D'Agostino, he shares what his data showed: an average ketone level near 1.2 mmol/L, daily insulin requirements declining from the mid-20s of units to around 16, and an episode in which glucose and ketones rose together after he had taken too little insulin.Dr. Lake describes how, in his case, one unit of insulin brought his ketones from approximately 3.0 to 0.9 mmol/L within about 20 minutes. He and Dr. D'Agostino use the experience to explore the distinction between nutritional ketosis and diabetic ketoacidosis, the essential role of adequate insulin, and why ketone readings must always be interpreted alongside glucose levels and clinical context.They also discuss insulin sensitivity during prolonged exercise, the practical challenges of adjusting insulin during endurance activity, and research suggesting that fat-adapted athletes may sustain high rates of fat oxidation at relatively high exercise intensities.Questions Answered in This EpisodeWhat did 21 days of continuous glucose and ketone monitoring reveal during a ketogenic, 1,000-mile cycling journey?How did prolonged endurance exercise affect Dr. Lake's daily insulin requirements?How is nutritional ketosis different from diabetic ketoacidosis, and what role does insufficient insulin play in DKA risk?What did Dr. Lake observe when his glucose and ketones began rising at the same time?How might fat adaptation influence fuel use and endurance performance?What are the practical limitations of continuous glucose and ketone monitoring for real-time insulin decisions?This conversation offers a rare look at 21 consecutive days of glucose, ketone, insulin, nutrition, and exercise data, while also emphasizing that Dr. Lake's experience is an individual case, not a substitute for personalized medical supervision.More Links:Shifting Gears, Dr. Lake's book, on AmazonType1Keto, Dr. Lake's site featuring the book and the Zero Five 100 projectSpecial thanks to the sponsors of this episode:✅ Zocdoc: Find and instantly book a top-rated doctor here.✅ fatty15: Get an additional 50% off a 90-day subscription starter kit with code METABOLICLINK.✅ Toups and Co: Get 25% off your first order with code METABOLIC.In every episode of The Metabolic Link, we'll uncover the very latest research on metabolic health and therapy. If you like this episode, please share it, subscribe, follow, and leave us a comment or review on whichever platform you use to tune in!You can find us on all your major podcast players here and full episodes are also up on our Metabolic Health Summit YouTube channel!Find us on social: InstagramFacebookYouTubeLinkedInPlease keep in mind: The Metabolic Link does not provide medical or health advice, but rather general information that does not serve as a substitute for a licensed healthcare professional. Never delay in seeking medical advice from an appropriately licensed medical provider for any health condition that you may have.

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by Raquel Baron, founder of Type One Together, to discuss the challenges, triumphs, and everyday realities of raising a child with type 1 diabetes. Diagnosed herself at age five, Raquel combines her lived experience with years of supporting families through Type One Together, an organization that provides trusted resources, educational programs, and a nationwide network of trained babysitters for children with type 1 diabetes. Together, Dr. Edelman and Raquel explore the emotional side of diabetes that often goes beyond blood sugars. They discuss helping children navigate school, sports, friendships, burnout, and growing independence, while giving parents practical strategies to reduce fear, build confidence, and create a healthier relationship with diabetes. The conversation also covers diabetes technology, social media, Afrezza for children, community support, and why perfection should never be the goal.Whether you're the parent of a newly diagnosed child or have been managing type 1 diabetes for years, this episode offers practical advice, reassurance, and reminders that children with diabetes can live full, active lives.✨ Subscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram:   / tcoydFacebook:   / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

 I ate two carb-heavy lunches... and my blood sugars stayed nearly flat. The secret wasn't taking more insulin—it was understanding how activity and insulin sensitivity work together.If you've ever wondered how exercise affects your blood sugars (and how to use it to your advantage), this video is for you. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

Clement Manyathela speaks to registered dietician Laura Mostert about recognising the warning signs of Type 1 diabetes in children, why early diagnosis is critical, and how families can successfully manage the condition while helping children live healthy, active lives. The Clement Manyathela Show is broadcast on 702, a Johannesburg based talk radio station, weekdays from 09:00 to 12:00 (SA Time). Clement Manyathela starts his show each weekday on 702 at 9 am taking your calls and voice notes on his Open Line. In the second hour of his show, he unpacks, explains, and makes sense of the news of the day. Clement has several features in his third hour from 11 am that provide you with information to help and guide you through your daily life. As your morning friend, he tackles the serious as well as the light-hearted, on your behalf. Thank you for listening to a podcast from The Clement Manyathela Show. Listen live on Primedia+ weekdays from 09:00 and 12:00 (SA Time) to The Clement Manyathela Show broadcast on 702 https://buff.ly/gk3y0Kj For more from the show go to https://buff.ly/XijPLtJ or find all the catch-up podcasts here https://buff.ly/p0gWuPE Subscribe to the 702 Daily and Weekly Newsletters https://buff.ly/v5mfetc Follow us on social media: 702 on Facebook https://www.facebook.com/TalkRadio702 702 on TikTok https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/Radio702 702 on YouTube: https://www.youtube.com/@radio702 See omnystudio.com/listener for privacy information.

We got a question in for our American Mamas, Teri Netterville and Kimberly Burleson...Dear Mamas, have you heard about the difference between type one and type two kinds of fun?If you'd like to ask our American Mamas a question, go to our website, AmericanGroundRadio.com/mamas and click on the Ask the Mamas button.

Richie Brave discusses UK drill with music commentator Sillah, as well as type 1 diabetes with content creator Lydia Brian. @1Xtra on socialProduced by Unedited for BBC Radio 1Xtra.

In today's episode, the conversation leads into something Ken feels deeply — the frustration of hearing people claim that Type 1 diabetes can be cured. As an autoimmune condition, Type 1 operates differently than Type 2, and the constant lumping together of both conditions by researchers, politicians, and the media creates real harm for people navigating the daily reality of living insulin dependent. Ken makes the case for why the principles of good health apply to everyone — but the mechanisms, and especially the medication piece, are not the same.Then the episode shifts into one of the most practical conversations Ken and Graham have had — the real tradeoffs between wearing a CGM and going without one. Graham has chosen to step away from CGM and rely on finger sticks and MDI, and Ken respects that. But he also gets honest about what that choice means when it comes to getting meaningful support from your endocrinologist. Without continuous data, your doctor is working with a handful of snapshots. With it, they can see the full picture — and that changes everything about the quality of care you can receive.

Aimee Perrin shares her journey of being diagnosed with type 1 diabetes at 16 and how she's navigated life, health, and resilience ever since. Featuring insights from Dr. Robert Kiltz and the Kiltz Method.If you want it more emotional, more clinical, or more punchy for algorithm performance, I can tailor it to your brand voice.

Melissa Slemp has lived with type 1 diabetes for 44 years — since she was diagnosed in 1982, before glucometers, before CGMs, back when insulin came from vials and syringes and "boiling your needles" was still a recent memory for a lot of people. In this episode, we trace that whole arc: what early management actually looked like, the high-risk pregnancy she navigated in the 90s, and the moment — after more than four decades on injections — she finally switched to a pump. If you've ever wondered what it's like to hand over that much control after that much time, this is the conversation. But the real heart of this episode is what happens to blood sugar when a woman with type 1 diabetes hits perimenopause. Melissa walks through her own experience of watching her basal insulin needs climb for no obvious reason, the years she spent without an explanation, and what she eventually learned about estrogen, progesterone, and insulin resistance — knowledge she says she had to dig up herself, because most endocrinologists and OBGYNs simply aren't trained in the overlap. That research became the reason she wrote Highs, Lows, and Hormones, a survival guide for women navigating diabetes from their monthly cycle through menopause. Along the way, we get into hormone replacement therapy, why so many women blame themselves before they ever think to blame their hormones, and the bigger pattern underneath it all: how much of diabetes research and care has historically centered men, and what it costs women when it does. There's also a genuinely great story about how Melissa met her husband, who also lives with type 1 — on the side of the road, of all places. This one's for anyone managing type 1 diabetes as a woman, anyone who loves someone who is, or anyone who's ever felt like their body changed the rules without telling them why. Chapters: 00:00 Cold open and introducing Melissa Slemp 01:21 Welcome, and 44 years living with type 1 diabetes 02:24 Diagnosed in 1982, before glucometers existed 04:03 Reframing: the best and hardest time to have diabetes 04:59 Growing up rural with limited access to healthcare 07:09 Early management: injections, mixed insulin, urine strips 07:46 A high-risk pregnancy in the 90s 08:13 Switching to a pump after 40+ years on injections 10:24 How Melissa met her husband, also living with T1D 13:06 Introducing the hormone and diabetes connection 20:14 Rising basal needs and insulin resistance in perimenopause 25:25 Community stories and menopause's hidden career toll 29:44 The gender gap in diabetes research 33:04 Hormones, GLP-1s, and insulin as hormone therapy 36:03 Advocating for yourself with doctors and specialists Resources: Melissa's Book: Highs, Lows, & Hormones: A Survival Guide for Women With Diabetes From Monthly Cycles to Menopause The Menopause Society Type 1 In Midlife Podcast

Every person with Type 1 diabetes has a date that changed their life forever. Ken and Graham get into whether we should celebrate it, fear it, or somewhere in between — and what your answer says about your relationship with this condition.It started with a simple question — do you know your diaversary?For Ken it's sometime in late June. For Graham it's around February 15th, the same month his family company was founded and named after him. But beyond the dates themselves, the question opened up one of the most honest conversations Ken and Graham have had about what it actually means to live with Type 1 diabetes for decades.Should we celebrate our diaversaries? Is it healthy to mark the day your life changed forever — or does it keep us tethered to a moment that's better left behind? Ken and Graham explore both sides of that coin and land somewhere that will resonate with anyone who has spent years navigating the emotional complexity of this condition.From there the conversation moves into one of the biggest questions in the Type 1 community — will there ever be a cure? Ken shares his honest perspective on what focusing on a cure does to your mental state, why he chooses to live in the present rather than wait for a finish line that may or may not come, and why that mindset shift is one of the most powerful things a person with diabetes can make.This one is equal parts honest, emotional, and grounding. It's exactly what the diabetes community needs to hear.

There is a fundamental link between diabetes and kidney care. But while there are many medications available to improve CKD outcomes in people with type 2 diabetes, the same options are not available for people with type 1. In this special episode, Dr. Neil Skolnik speaks with Janet McGill, MD, MA, FACE, FACP about the underdiscussed prevalence of CKD in type 1 and the importance of continued development in this area. This special episode is sponsored with support from Bayer. Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts, Amazon Music, Spotify, or your preferred podcast platform. Presented by: Neil Skolnik, MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Janet B. McGill, MD, MA, FACE, FACP, Professor of Medicine at the University of Washington's John T. Milliken Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research Selected References: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026. The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1):S246–S260 Finerenone in Type 1 Diabetes and Chronic Kidney Disease. N Engl J Med 2026;394:947-957 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020;383:2219-2229 Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020;383:1436-1446 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med 2024;391:109-121

Anxiety with type 1 diabetes isn't always about low blood sugars... it's often about the uncertainty of what might happen.The goal isn't to eliminate fear—it's to build enough certainty that fear no longer controls your decisions.If dosing anxiety has been holding you back, this message is for you.

Diabetes technology is evolving faster than most people realize — and Ken and Graham break down exactly what that means for your day-to-day management. Plus, Ken closes with something every person living with diabetes needs to hear right now.

Guest: Julianne LallyShow Notes:Type 1 diabetes doesn't start with symptoms, it starts silently. In this episode, early screening expert Julianne Lally reveals how autoantibody testing can detect risk years before diagnosis and why that window matters. Learn how early detection can reduce complications, what families should know about screening access, and how new innovations are working to make early screening the norm, not the exception.Guest Bio:Julianne Lally, DMSc, MHS, PA-C, is Associate Director of Medical Affairs at Breakthrough T1D. She focuses primarily on screening and early detection of type 1 diabetes, leads the Early Detection Pilot Program and facilitates healthcare professional education efforts. Julianne's professional interest in T1D stems directly from her own personal diagnosis at age twelve. Doctorate of Medical Science, Masters of Health Science, and Physician AssistantQuote:“It's really beautiful to think about a future where people are diagnosed in their doctor's office and not in the hospital or ICU.”Question of the Day:If you have a family history of autoimmune conditions, type 1 diabetes in particular. Have you ever considered screening for type 1 diabetes? Why or why not?On This Episode You Will Learn:Why early detection of type 1 diabetes is so important.How type 1 diabetes can be detected before symptoms develop..Common symptoms families should watch forHow screening for type 1 diabetes worksNew research and treatments that could delay or prevent the disease.Connect with Yumlish!Yumlish Website: YumlishYumlish on Instagram: @yumlish_Yumlish on Facebook: YumlishYumlish on Twitter: @yumlish_Yumlish on LinkedIn: YumlishConnect with Julianne Lally!Website URL: Type 1 Diabetes Screening & Early DetectionInstagram URL: @BreakthroughT1DFacebook URL: Breakthrough T1D Twitter(X) URL: @BreakthroughT1DLinkedIn URL: linkedin.com/in/juliannemlally/

Check out this week's Coworker Compatibility episode between the Type 1 (striving to feel perfect) and the Type 8 (striving to feel powerful). When you tune in, you'll hear about:the strengths of this duo at work potential friction points communication styles of each leadership vs. direct report dynamics of each growth opportunities in the workplaceResources + Links:Learn more about the 3-part Dream Team Momentum program: enneagrammba.com/enneagram-team-workshopsRun your own Enneagram Workshop: enneagrammba.com/enneagram-workshop-kitConnect with Sarah on LinkedIn: linkedin.com/in/sarahlynnwallace/Take the 2-question Enneagram quiz: enneagrammba.com/blog/enneagramtestWork with Sarah - workshops, speaking, and team facilitation: enneagrammba.com/enneagram-speakerHave a request for a future episode? Drop a text here! 

From 70% to 95–100% Time in Range.

It's In the News - a look at the top diabetes headlines and stories happening now. Our top stories: More information about type 1 and COVID, including the vaccine, why is the latest GLP-1 medication, not yet FDA approved, showing up all over the place, what table sugar and vinegar could mean for drug costs, a new inhaled insulin study and much more  I'll see you at Friends for Life next week. Come find me at Table T18 Learn more about our in-person events here: https://diabetes-connections.com/events/ Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Transcript & links:    Okay.. our top story this week: XX A large Swedish study found that the increased risk of being diagnosed with type 1 diabetes after COVID-19 infection is mostly limited to the first 30 days after infection and does not continue long term. Researchers followed nearly the entire Swedish population under age 80 from 2020 through 2023 and found that while SARS-CoV-2 infection was linked to a temporary rise in new type 1 diabetes diagnoses, the risk declined over time. The study also found no evidence that COVID-19 vaccination increases the long-term risk of developing type 1 diabetes. Vaccination did not significantly change the relationship between COVID-19 infection and diabetes risk, and any small increase in diagnoses seen among adults shortly after a first vaccine dose was not seen after later doses or during longer follow-up. The researchers concluded that their findings do not support changing current COVID-19 vaccination recommendations because of concerns about type 1 diabetes risk. https://www.infectiousdiseaseadvisor.com/news/covid19-infection-may-increase-short-term-type-1-diabetes-risk/ XX Two new studies are challenging the traditional view that type 1 diabetes develops solely because the immune system attacks insulin-producing beta cells. Researchers from Indiana University found evidence that beta cells themselves may play an active role in determining whether they survive or succumb to the stresses that lead to type 1 diabetes. In the first study, scientists discovered that some healthy human beta cells can quickly activate an antiviral defense system when exposed to interferon-alpha, an immune signal often produced during viral infections. This response relies on molecules called reactive oxygen species (ROS), which are usually associated with cell damage but, in this case, appeared to help switch on protective antiviral genes. Researchers found this defense program in healthy cells and in people at risk for type 1 diabetes, but not in beta cells from people who already had the disease. The findings suggest that losing this built-in defense mechanism may make beta cells more vulnerable during the development of type 1 diabetes. The second study focused on autophagy, the process cells use to recycle damaged or worn-out components. Using a new imaging technique, researchers observed that beta cells in a mouse model of type 1 diabetes showed defects in autophagy before blood sugar levels began to rise and even before a full immune attack was underway. This suggests that problems inside the beta cells may occur early in the disease process rather than being caused entirely by the immune system. Together, the studies point to a more complex picture of type 1 diabetes. While they do not show that beta-cell defects cause the disease, they suggest that differences in how beta cells respond to stress, viral signals, and cellular damage may influence who develops type 1 diabetes and how the disease progresses. https://medicalxpress.com/news/2026-06-beta-cells-players-diabetes.html XX Researchers have created the most detailed map yet of how the human pancreas develops during childhood, offering new clues about why children are especially vulnerable to developing diabetes. The study, published in Nature Communications, examined pancreatic tissue from 123 children without diabetes, ranging from newborns through age 10. Using advanced imaging techniques, scientists tracked how insulin-producing islet cells grow and mature during the first decade of life. The researchers found that pancreas size varies dramatically at birth, with some infants having pancreases nearly four times larger than others. They also discovered that insulin-producing beta cells grow more slowly after birth than previously thought, suggesting that much of a person's lifelong beta cell capacity may be established before birth and during early childhood. Other findings showed that insulin-producing cells mature earlier than glucagon-producing cells and that new hormone-producing cells may continue to form after birth. The researchers hope this new understanding of pancreas development will help scientists identify diabetes risk earlier and develop better strategies for prevention and treatment in children. https://news.vumc.org/2026/06/29/unlocking-diabetes-secrets-pediatric-organ-donors-help-map-a-path-to-a-cure-and-prevention/   XX At the American Diabetes Association annual meeting, 2-year results from the SUPPRESS-EARLY trial showed that initiating tirzepatide (Mounjaro, Zepbound) early in the course of type 2 diabetes led to substantially higher rates of near-normal glycemic control and also led to broader metabolic improvements compared with intensive conventional therapy.   In this MedPage Today video, investigator Stefano Del Prato, MD, of the University of Pisa in Italy, discusses the findings.     Following is a transcript of his remarks:   What happened is that in the tirzepatide-treated arm, 85% of the population at the end of the second year was on the maximum dose of tirzepatide 15 mg. And then the remaining 15 with the different doses.   Interestingly, in the population that had been treated with the intensive conventional approach, 85% of them ended up to have, on top of metformin, a GLP-1 receptor agonist, mainly represented by subcutaneous semaglutide [Ozempic, Wegovy], 60+%, another 15% on oral semaglutide [Rybelsus], and the remaining on dulaglutide [Trulicity].   And I have to say that maybe the recommendation to really push along the line to try to achieve and to strive to achieve [glycemic] control was successful in these individuals. Because the population that had been recruited in the study started off with a baseline A1C of 7.8% and it went down to 6.3% in the conventionally intensive treatment, which is not bad at all, on average is below the target of 6.5%.     However, when we look at the effect of tirzepatide, the final level of A1C at the end of the second year was 5.6%, which is on average below the upper limit of the normal range for A1C, 5.7%. This also translates into more people not only achieving normal glycemia, if we can define normal glycemia as A1C below 5.7%, greater than what we observed in conventionally treated individuals. So it was around three times more people achieving an A1C of 5.7%, in the range of around 65%, as compared to 28% with people on a conventional optimized treatment.   Now, this is not surprising knowing the potency of tirzepatide. But again, going back to the rationale of the design, can we change what is the natural history of the disease? This seems to be at least of interest and it's possibly changing the trajectory of the disease for glycemic control, as I mentioned, but also in terms of the body weight and waist circumference because both body weight and waist circumference went much lower with tirzepatide compared to the conventional treatment.   Tirzepatide also was associated with an improvement in the lipid profile, in particular with the LDL, triglycerides, and the triglyceride concentration and non-HDL cholesterol, and also with a statistically significantly lower systolic blood pressure with a numerical reduction in the diastolic blood pressure.   And also the other thing that probably will ... become more apparent with the study continuing is that the investigators were allowed to add on any other treatment ... needed to achieve their target. So tirzepatide was just metformin and tirzepatide. In the control group, there was already 10% of people who were receiving two drugs on top of the metformin.   So another potential result of the trial is that it's possible to achieve and maintain better glycemic or better metabolic control over the time without really needing to increase the number of medications in order to achieve that goal. And we know that type 2 diabetes is a progressive condition often requiring intensification of the treatment.   So these initial results really stand for a great opportunity with tirzepatide. Of course, we need to wait for the 4 years just to confirm that this is indeed the case, but the initial result seems to point along that line. https://www.medpagetoday.com/meetingcoverage/adavideopearls/121967 XX A study from the University of Virginia found that high blood pressure is extremely common among people with diabetes, even among those who believe their blood pressure is under control. Researchers measured blood pressure in 172 adults with type 1 or type 2 diabetes during routine eye clinic visits and found that only 8% had normal readings. About half had stage 2 hypertension, and more than 10% had blood pressure levels high enough to be considered a medical emergency. The study also revealed that many patients were unaware of how serious their blood pressure problems were. Among those who thought their hypertension was well controlled, more than half still had stage 2 hypertension. Nearly 60% of participants were advised to contact their primary care provider, and one patient required an emergency department referral. Most patients supported blood pressure screening during eye exams, leading researchers to suggest that routine blood pressure checks in ophthalmology clinics could help identify undiagnosed or poorly controlled hypertension before it leads to serious complications such as heart attack, stroke, or worsening diabetic eye disease. https://medicalxpress.com/news/2026-06-routine-eye-exams-reveal-stage.html XX What is going on with retatrutide? This is the next generation GLP-1 but it's not authorized outside of clinical trials. Big investigation by CBS shows retatrutide is for sale all over the internet, a phenomenon they say has no modern precedent. CBS News identified more than 120 websites selling or promoting retatrutide, including more than 50 clinics staffed by licensed medical professionals. After being contacted by CBS News, at least 21 clinics abruptly removed retatrutide from their websites or changed the language to state they don't offer it. Others defended prescribing it, saying they're confident enough in results from clinical trials sponsored by drugmaker Eli Lilly that they didn't need to wait for the FDA's independent, rigorous review. An FDA spokesperson said retatrutide "has not been found safe or effective for any condition," adding that it "cannot be manufactured or distributed except for investigational use." The Justice Department is prosecuting two cases – in Utah and Florida – involving the sale and prescription of retatrutide. But the first line of enforcement is often at the state level. Ohio's Board of Pharmacy has taken action against several pharmacies and clinics providing retatrutide, and just last month, Alabama's Medical Board warned physicians against prescribing research-grade medications. The FDA has sent 14 warning letters to companies that have advertised retatrutide since 2024. Of these, at least six have continued to offer it online, including a business called Pink Pony Peptides. A TikTok account associated with the firm responded to the warning in April by taunting the FDA, boasting that the business "just had the best 24 hours ever." In May, Eli Lilly announced that participants in a large clinical trial taking the highest dose of retatrutide lost an average of 28% of their body weight over 80 weeks. Side effects – including nausea, diarrhea, constipation and vomiting – were comparable to similar therapies, the company said. "Anyone purporting to sell retatrutide to consumers is breaking the law," an Eli Lilly spokesperson said https://www.cbsnews.com/projects/2026/experimental-weight-loss-drug/ XX Pioneering research has developed a new way of creating carbohydrate-based medicines, which could ultimately replace costly drugs for common health conditions, using two cheap basic ingredients – table sugar and vinegar. These medications include SGLT2 inhibitors, widely prescribed drugs used to treat type 2 diabetes, heart failure and chronic kidney disease. Co-lead author Professor Phil Baran, Dr. Richard A. Lerner Endowed Chair at Scripps Research, in San Diego, California, said: "The point of this is to show that anyone in a garage can make an SGLT2 inhibitor with reagents that are widely available. We have not patented this method, so we welcome any generic drug company – or anyone else – who wants to use it to help bring costs down for patients." https://www.newswise.com/articles/new-study-shows-table-sugar-could-hold-a-cheaper-quicker-key-to-making-vital-drugs-for-diabetes-heart-failure-and-chronic-kidney-disease XX England and Wales approve teplizumab to slow progression of T1D. At the moment, the Scottish Medicines Consortium does not have an appraisal of Tzield on the go, so, there is likely to be a disparity in access within the UK for the time being. In Northern Ireland, access will depend on a review and adoption of NICE guidance.  Sanofi is expecting to see an uptick in momentum thanks to two subsequent FDA approvals, one in children as young as one with stage 2 T1D, and a second to delay the decline in endogenous insulin production in children aged eight to 17 years recently diagnosed with stage 3 T1D. btw you might here more people referring to stage 4 diabetes. They've added that to include people diagnosed with type 1 who've been on insulin for a longer period of time – basically long enough to not be eligible for the current guidelines for Tzield. https://www.bbc.com/news/articles/ce8mzd94r76oXX XX Obesity Association, a division of the American Diabetes Association® (the association), announced the next section in the Standards of Care in Overweight and Obesity, "Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults," published in Diabetes, Obesity, and CardioMetabolic CARE® and BMJ Open Diabetes Research & Care.  Key highlights of the guidance: Early screening: Annual BMI screening with emphasis on tracking weight trends to identify risk earlier, including a longitudinal life-event weight graph tool for standardized assessment. Enhanced diagnosis: Combines BMI with waist measurements and population-specific thresholds to improve accuracy. Notably, the guidelines recommend that BMI in the overweight range together with central adiposity measurements warrant a formal obesity diagnosis. Comprehensive evaluation: Holistic assessment including medical, behavioral, and social factors. Offers a fully integrated obesity diagnostic algorithm. Risk stratification: Use of tools like the Edmonton Obesity Staging System to guide care. Chronic care approach: Ongoing monitoring and follow-up to support long-term management. Reducing bias: Promotes person-centered, non-stigmatizing care and system-level improvements at the clinical workflow level and encourages screening for prior weight bias/stigma experiences. https://www.prnewswire.com/news-releases/new-standards-of-care-in-overweight-and-obesity-section-screening-diagnosis-evaluation-and-staging-of-obesity-in-adults-302809670.html XX Dexcom (Nadsaq:DXCM) today announced the launch of its fully reimagined Stelo over-the-counter (OTC) sensor app experience. San Diego-based Dexcom plans to formally begin the new app rollout in July for Apple iPhone and Android users in the U.S. Dexcom said its reimagined app aims to make glucose insights easier to understand and act on. It hopes to help build awareness of how food, activity, sleep and stress influence overall wellbeing.   The company also reiterated plans to launch Stelo internationally. It expects to bring the sensor to the UK, Australia, New Zealand and South Korea later this year, continuing into 2027. https://www.drugdeliverybusiness.com/dexcom-launches-enhanced-stelo-app/ XX MannKind Corporation recently announced it received a grant from Breakthrough T1D to support the INHALE-1 clinical study of Afrezza, its ultra rapid-acting inhaled insulin, in newly diagnosed pediatric type 1 diabetes patients aged 10 to under 18 years. This external funding for a trial focused on early use of Afrezza in children highlights growing third-party support for inhaled insulin in pediatric diabetes care. https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-mnkd/mannkind/news/afrezza-pediatric-trial-grant-might-change-the-case-for-inve XX Alexander Zverev heads into Wimbledon with plenty of momentum. The French Open champion returns to the All England Club looking to build on his first Grand Slam title and gain ground on Carlos Alcaraz in the race for the No. 2 spot in the ATP rankings. Zverev has an opportunity to make up points quickly after a first-round exit at Wimbledon last year. But his final tune-up before Wimbledon came with an unexpected challenge. During his semifinal loss to Taylor Fritz at the Halle Open, Zverev said a malfunctioning glucose sensor led to serious diabetes management issues on court. The sensor incorrectly showed his blood sugar was high when it was actually low, causing him to take more insulin than needed. "I had huge problems with the sugar because the sensor I use gave me a completely incorrect reading," Zverev said after the match. "During the match, or rather during the first 45 minutes, I had to consume about 350 grams of sugar. I felt absolutely terrible." Despite feeling unwell, Zverev pushed the match to three sets before falling 6-7(4), 6-4, 7-5 to Fritz. He credited his opponent with playing the better match and said the diabetes-related issue was not an excuse for the result. Zverev, who was diagnosed with type 1 diabetes at age 4, uses Medtronic diabetes technology to help manage his glucose levels while competing on the ATP Tour. He said the sensor error was the first major problem he has experienced after nearly a decade of using the technology. The German said the incident should not affect his Wimbledon preparations. With the sensor issue behind him, Zverev will begin his Wimbledon campaign focused on adding another strong result to what has already been a breakthrough season.   https://www.reuters.com/sports/tennis/zverev-says-glucose-sensor-malfunction-affected-halle-semi-final-loss-fritz-2026-06-21/

In this episode of the TCOYD Podcast, Dr. Steve Edelman is joined by pediatric endocrinologist Dr. Anna Cymbaluk, along with Philip and his father Jim, to discuss the recent FDA approval of Afrezza inhaled insulin for children and adolescents living with type 1 diabetes. Dr. Cymbaluk served as an investigator on the INHALE-1 trial, while Philip participated in the study himself, providing a unique real-world perspective on what it is like to transition from injections to inhaled insulin, and Philip's dad, Jim provided the parent perspective as well as addressed parental concerns that might have arisen.The conversation focuses on the INHALE-1 study and the unmet challenges that continue to exist around mealtime insulin dosing in pediatric diabetes care. Dr. Cymbaluk reviews the trial design, glucose outcomes, safety data, patient satisfaction findings, and the practical realities of introducing inhaled insulin into everyday diabetes management. Philip and Jim share how Afrezza impacted school, sports, social situations, and the day-to-day burden of diabetes, particularly around pre-bolusing, corrections, and avoiding multiple injections throughout the day.Dr. Edelman and Dr. Cymbaluk also explore how Afrezza is dosed, how inhaled insulin differs from injected insulin, who may be a good candidate, and where it may fit alongside pumps and automated insulin delivery (AID) systems. For families looking for more flexibility, fewer mealtime barriers, and another option in the diabetes toolbox, this episode provides an honest look at the benefits, limitations, and real-world experience of inhaled insulin in children and teens.Key Topics• The FDA approval of Afrezza for children and adolescents living with type 1 diabetes• The design and results of the INHALE-1 pediatric clinical trial• Patient satisfaction and quality-of-life outcomes from the study• The challenges of pre-bolusing and mealtime insulin management in children and teens• How inhaled insulin compares to traditional mealtime injections• Dosing strategies, cartridge sizes, and insulin conversion considerations• Using Afrezza for corrections, meals, and post-meal dosing• The role of continuous glucose monitoring (CGM) when using inhaled insulin• Safety findings, lung-function monitoring, and cough management• Who may be a good candidate for Afrezza—and who may not be• Benefits for active children, athletes, and those participating in sports• Social situations, injection avoidance, and reducing the burden of diabetes management• Using Afrezza alongside insulin pumps and automated insulin delivery (AID) systems• The importance of having more treatment options to individualize diabetes careSupported by an unrestricted educational grant from MannKind CorporationSubscribe for practical diabetes management tips, technology updates, and treatment breakthroughs that help people with diabetes live healthier, more flexible lives.More diabetes resources:Website: tcoyd.orgBlog: tcoyd.org/blogPodcast: tcoydthepodcast.transistor.fmInstagram: / tcoydFacebook: / tcoydStay connected! Sign up for our monthly newsletter here!Support TCOYD's educational programs: tcoyd.org/donate ★ Support this podcast ★

We start the pod with a poo story and end it with one. Really hitting peak podcasting performance lol!

Alex Tolwinski… known online as @TypeOneAlexx… built a pretty recognizable T1D presence on social media by doing what everyone told him he couldn't do: feasting on Crumble cookies, Chinese buffets, and dirty sodas, and posting every blood sugar along the way. But behind the funny viral videos is a guy who spent years feeling completely alone with his diagnosis, and who eventually found his way back through community.In this episode, Alex joins Lauren to talk about what it actually looks like to live boldly with T1D, why he'll never delete a negative comment, and the moment in college that made him realize he didn't have to figure this out by himself.In this episode you'll hear:Why Alex intentionally ate 6 Crumbl Cookies in one sitting, and what happened to his blood sugar afterwardThe terrifying 24 mg/dL and 28 mg/dL lows that led to paramedics, police officers, and complete memory lossWhat Alex says is the hardest part of Type 1 diabetes (and it's not high blood sugar)How Alex handles the comments that claim he doesn't take care of himselfWhy he answers "what does reclaiming life with T1D mean to you?" with just one wordWHAT'S NEXT:

Type 1 Diabetes can feel like living with invisible thorns.The hard truth? Avoiding the uncomfortable parts—exercise, new foods, insulin adjustments, and learning your body's patterns—doesn't make them disappear. It only lets them keep stealing your freedom.Growth happens when we lean into discomfort, collect data, learn from it, and take action.Don't ask, "Can I do this?"Start asking, "How can I do this?"That's where freedom begins. >> ENJOY!Join The Tribe: https://thewarriorstribe.comPurchase your copy of "The Blood Sugar Freedom Formula" book TODAY!https://www.amazon.com/dp/1964811880?psc=1&smid=ATVPDKIKX0DER&ref_=chk_typ_quicklook_imgToDpGrab your free ticket to this advanced T1D training here:https://diabetesinaction.comFree T1D Support Group Here: https://diabetesinaction.com/join-group-1---------Welcome to the Pardon My Pancreas podcast!! This show is all about REAL life with type 1 diabetes, understanding fluctuations, and how to stabilize your blood sugar for good. Your host is Matt Vande Vegte is a certified personal trainer, nutritionist, and type 1 diabetic whose biggest goal in life is to help people with diabetes around the world live their lives fearlessly. Looking for an online health coaching program to help you live your best life? Go to https://www.ftfwarrior.com to learn more about his program for diabetics only that is focused on helping you reach your goals while living a happier and healthier life. Join the Tribe today!This podcast is sponsored by FTF Warrior - An online health and fitness coaching company for type 1 diabetics dedicated to helping them master their blood sugars through any activity, exercise, or meal!https://www.ftfwarrior.comFollow Matt here:Instagram: https://www.instagram.com/ftfwarrior/Facebook: https://www.facebook.com/ftfwarrior/YouTube: https://www.youtube.com/c/ftfwarrior------------------------------------------------------Disclaimer: While we share our experiences with diabetes, nothing we discuss should be taken as medical advice. Please consult your doctor or medical professional for your health and diabetes management. 

This episode of the PeerDirect Medical News Podcast highlights three major developments shaping diabetes and hematologic oncology care. First, the FDA expanded approval of teplizumab for selected children and adolescents with newly diagnosed Stage 3 type 1 diabetes, making it the first therapy to modify disease progression after diagnosis by preserving beta-cell function. Additional stories review evidence supporting continuous glucose monitoring in basal insulin-treated type 2 diabetes and promising Phase III data showing talquetamab-based bispecific antibody regimens improve outcomes in relapsed or refractory multiple myeloma.

It's In The News - a look at the top diabetes stories and headlines happening now!   Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcript: fall Detroit and Seattle.   Okay.. our top story this week: XX The FDA approved Tzield for use in stage 3 T1D – that's what we used to just call type 1. It's the stage where the body can no longer produce enough insulin on its own to manage blood sugars you need to start insulin. This approval is for kids ages 8-17 within 8 weeks of a stage 3 T1D diagnosis. It comes after the PROTECT trial and it's the first approval of a disease-modifying therapy for stage 3 T1D. https://www.prnewswire.com/news-releases/breakthrough-t1d-celebrates-approval-of-tzield-for-use-in-stage-3-type-1-diabetes-in-the-us-302799532.html XX Encouraging results from a small study of islet cell transplantation in people with type 1 where now all 12 participants in the trial are currently living without external insulin after receiving transplanted insulin-producing islet cells.   The study, led by researchers at the University of Chicago, tested an experimental immune therapy called tegoprubart Te-GO-Proo-Bart. The drug is designed to prevent the body from rejecting transplanted cells while avoiding some of the side effects associated with standard anti-rejection medications. You've probably heard about this as the Eledon study – many of the participants have been very active on social media. It was presented at ADA. transplants.https://www.breakthrought1d.org/news-and-updates/tegoprubart-islet-transplant-all-participants-off-external-insulin/ XX New data suggest that acmopatide (ack-MOW-puh-tyd) (CT-868), an experimental once-daily dual GLP-1/GIP receptor agonist, may help people with type 1 diabetes improve blood sugar control, lose weight, and reduce insulin use. Across all doses, participants lost up to 7% of their body weight and reduced insulin use by as much as 15%. The study lasted just 16 weeks, so researchers say longer-term data will be needed to determine whether the benefits can be maintained and whether lower insulin requirements can be achieved without increasing the risk of hypoglycemia. XX A new combination therapy that pairs an amylin analog with semaglutide improved both blood sugar levels and weight loss in several groups of people with type 2 diabetes. The once-weekly injectable, known as CagriSema (KAG-ruh-SEM-uh), was evaluated in three Phase 3 REIMAGINE studies. In people early in the course of type 2 diabetes, researchers reported A1C reductions of up to 1.8 percentage points and significant weight loss compared to placebo after 40 weeks of treatment. Investigators also noted improvements in several cardiometabolic risk factors, including blood pressure. https://www.medpagetoday.com/meetingcoverage/ada/121658 XX Stelo for kids is now FDA cleared.. the over the counter Glucose Biosensor System is now approved for children as young as 2 years old who do not use insulin. The FDA identified pediatric prediabetes as a growing public health concern motivating the expanded indication, noting OTC CGMs can help younger users and their caregivers build glycemic awareness, track patterns in response to me https://www.hcplive.com/view/fda-clears-first-otc-glucose-monitor-for-children XX Insulet presented new data from its STRIVE and EVOLUTION 3 studies showing improved glucose control with its next-generation Omnipod 6. That's , the company's upcoming hybrid closed-loop system for people with type 1 and type 2 diabetes. The main difference between the Omnipod 6 and Insulet's current Omnipod 5 patch pumps is that the new system has a lower glucose target of 100 mg/dL and better Bluetooth connectivity Insulet also shared progress on a fully closed-loop system designed specifically for type 2 diabetes. It  does not require carb-counting or insulin bolusing ahead of meals. Physicians also don't need to program the starting settings.   XX Abbott shared new research highlighting challenges in identifying and managing diabetic ketoacidosis (DKA). The studies coincide with the company's development of Libre Duo, a dual glucose-ketone sensor that continuously tracks both measurements. Abbott reported that DKA can be difficult to recognize when patients first arrive at the hospital, based on data from more than 100,000 people. The company has submitted the dual sensor to the FDA and recently received CE Mark approval in Europe. More news from ADA including info from Dexcom, Sequel, Sensonics and the world loses a tireless T1D advocate.. that's all to come right after this. --   Back to the news.. XX   Dexcom announced its acquisition of Nutrisense, a company that combines continuous glucose monitoring with nutrition coaching and behavioral support. At ADA, the company also presented results from the CONNECT study showing significant A1C reductions and improved glucose control in people with type 2 diabetes not using insulin. The findings add to growing evidence supporting CGM use beyond intensive insulin therapy. We did an episode with CEO Jake Leach at ADA about these announcements as well as updates on G8, their hospital product and much more. XX Sequel Med Tech reported positive clinical results evaluating its twiist automated insulin delivery system in people with type 2 diabetes. The study showed improvements in A1C and time in range over 13 weeks XX Senseonics presented new real-world data supporting the performance of its Eversense 365 implantable CGM. The analysis included more than 12,000 sensors and demonstrated sustained accuracy and effectiveness in both open-loop and automated insulin delivery settings. Researchers also evaluated Eversense use with Sequel Med Tech's twiist system. The findings support broader use of long-term implantable CGM technology.   -- MiniMed used ADA 2026 to spotlight two recently cleared diabetes management systems. The MiniMed Flex pump offers a smaller, smartphone-controlled insulin pump option, while MiniMed Go combines the InPen smart insulin pen with Abbott's Instinct sensor. The products received FDA clearance earlier this year. XX Tandem Diabetes Care highlighted data supporting the use of its Control-IQ automated insulin delivery technology during pregnancy. Results from the CIRCUIT trial showed users spent approximately three additional hours per day in the recommended pregnancy glucose range compared with standard therapy. The findings helped support recent regulatory approvals for pregnancy use in both Europe and the United States. Tandem also expanded indications for adults with type 2 diabetes. XX Beta Bionics presented real-world data from the first three years of iLet Bionic Pancreas use. The company reported a 25% improvement in time in range among users, along with positive feedback from clinicians about simplified diabetes management. The iLet system requires only a user's weight to begin therapy and eliminates carbohydrate counting. Beta Bionics also highlighted growing access to near-real-time outcomes through its public data dashboard. XX MannKind presented new findings supporting its Afrezza inhaled insulin at ADA 2026. A post-hoc analysis of the INHALE-1 study found that pediatric users reported greater treatment satisfaction compared with those using rapid-acting injected insulin. The results come shortly after FDA approval expanded Afrezza's indication to include children. We did a bonus episode with one of the lead investigators of the study that lead to that approval. XX Adaptyx presented early clinical data supporting a wearable sensor that continuously measures cortisol levels. The device successfully tracked cortisol changes during both controlled testing and overnight monitoring in first-in-human studies. Company leaders say cortisol plays a major role in conditions including diabetes, hypertension, and depression. The technology uses synthetic DNA-based molecular switches to generate real-time readings.   XX Biolinq shared new clinical findings for its Shine continuous glucose monitoring system. The needle-free device combines glucose monitoring with activity and sleep tracking .The system received FDA clearance in 2025. They're also looking at measuring lactate through the sensor. XX Long-time T1D advocate Kent Schnakenberg died last week. Schnakenberg was known in his community for using his love of bicycling to raise awareness of Type 1 diabetes. He also advocated for improving the lives of those living with the disease. Inspired by his niece, Michelle, who was diagnosed with juvenile diabetes when she was 13 years old, since 2014 he has traveled around the country cycling thousands of miles, speaking to hundreds and hundreds of kids and raising Money. According to Schnakenberg's family, he suffered a head trauma incident in his home on Wednesday. I spoke to Kent years ago – I believe the first year of the podcast. A sad loss but wonderful to see so many tributes and memories posted on social media in the last few days. https://diabetes-connections.com/john-costik-co-creator-of-nightscout-team-schnak/ https://www.wibw.com/2026/06/12/team-schnak-founder-kent-schnakenberg-passes-away/ XX And finally. Alexander Zverev (ts-ver-uhv) won the French Open, his first Grand Slam title. He lives with type 1, he paused a couple of time to check his blood sugar. He was diagnosed at age 4 and partners with Medtronic. "Becoming a professional tennis player was always my dream," Zverev shared in an article posted by Medtronic. "Early on, I was told that competing at the highest level with diabetes was impossible — but my family and I refused to accept that. That's why I'm partnering with Medtronic Diabetes: I want every person with diabetes to feel empowered to live the life they want." He also has a foundation committed to children with type 1 diabetes. Among other things, the life-saving insulin and other essential drugs are provided – also in developing countries." https://www.mensjournal.com/news/alexander-zverev-diabetes-wins-french-open-2026-medical-condition

Alexis is a Type 1 diabetic mom of three boys from Nevada. Her first birth was a 37-week induction due to her diabetes that ended in a vaginal delivery. For her second birth, Alexis was told she needed a cesarean because her baby was expected to be "massive," but after birth, he was perfectly average-sized. In the OR, her providers admitted their prediction was wrong, and Alexis was devastated. Alexis was determined more than ever to educate herself and advocate hard for her next birth.During her third pregnancy, Alexis navigated polyhydramnios, multiple provider changes, and concerns about possible fetal heart abnormalities that ultimately turned out to be no issue after birth. But even with these challenges, still advocated and achieved her unmedicated VBAC. Her labor ended with a shoulder dystocia with her baby having a broken arm, but with a smooth recovery. Alexis shares how TVL, research, informed decision-making, educating her support team, and using the B.R.A.I.N. acronym helped her throughout her pregnancy and birth journey.Note from Alexis: “There was never a real explanation as to why they suspected he had ARSA, the increased velocity, or the small hole in utero. And as a tip for anyone in labor, honey is considered a clear liquid, and the cheap honey bears at Walmart are great during labor! I took swigs off of it during labor for energy and to keep my blood sugar up. The midwife came to check on me at one point mid-swig and said that was the first time she had seen that in her 25 years. I couldn't find honey sticks locally for a reasonable price, but I could find local honey bears.”Keywords: VBAC, Type 1 diabetes, juvenile diabetes, induction, 37-week induction, scheduled cesarean, suspected macrosomia, big baby, polyhydramnios, unmedicated VBAC, shoulder dystocia, broken humerus, birth injury, fetal heart concerns, ARSA, informed consent, B.R.A.I.N., VBAC prepNatural Birth for Type 1 Diabetics Facebook GroupT1D Pregnancy Course Needed Website: Code TVL for 20% OffThe Ultimate VBAC Prep Course for ParentsOnline VBAC Doula TrainingAdvertising Inquiries: https://redcircle.com/brands

Dr. Ian Lake has worked as a doctor in the NHS for nearly four decades, most of this time as a general practitioner. After being diagnosed with LADA Type 1 Diabetes at age 36 and managing it conventionally for 20 years, he adopted the low carb diet and has been following it for the past 10 years. He is a founding member of the Public Health Collaboration in the U.K. and has conducted several important research projects investigating the connection between low carb diets and human health. He has also worked with Dr. Tro and others to produce the Type 1 Consensus Statement. In this episode, Drs. Tro and Ian talk about… (00:00) Intro (03:30) The mental and physical health challenges faced by Type 1 Diabetics and how these challenges have traditionally been dealt with (13:44) Ketoacidosis, what insulin does, and modern methods/dietary reccomendations for controlling Type 1 Diabetes (25:45) How Dr. Lake's colleagues have responded to his ideas regarding Type 1 and ketogenic diets (38:00) Dr. Lake's new book, Shifting Gears, on the need to move from a glucose-centric view of Type 1 to a holistic, healthy human being perspective (50:23) Outro For more information, please see the links below. Thank you for listening! Links: Please consider supporting us on Patreon: https://www.lowcarbmd.com/ Resources Mentioned in this Episode: Dr. Ian Lake's last appearance on the LCMD Podcast: https://lowcarbmd.com/podcast/episode-368-dr-ian-lake/ Dr. Ian Lake: X: https://twitter.com/idlake Type1Keto: https://type1keto.com Type 1 Consensus Statement: https://journalofmetabolichealth.org/index.php/jmh/article/view/100 Case report: Ketogenic diet alleviated anxiety and depression associated with insulin-dependent diabetes management: https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2024.1404842/full Shifting Gears (New Book): https://type1keto.com/product/shifting-gears-the-1000-mile-ride-that-changed-my-mindset-on-type-1-diabetes/ Dr. Brian Lenzkes:  Website: https://arizonametabolichealth.com/ Twitter: https://twitter.com/BrianLenzkes?ref_src=twsrc^google|twcamp^serp|twgr^author Dr. Tro Kalayjian:  Website: https://toward.health Twitter: https://twitter.com/DoctorTro IG: https://www.instagram.com/doctortro/ Toward Health App Join a growing community of individuals who are improving their metabolic health; together.  Get started at your own pace with a self-guided curriculum developed by Dr. Tro and his care team, community chat, weekly meetings, courses, challenges, message boards and more.  Apple: https://apps.apple.com/us/app/doctor-tro/id1588693888  Google: https://play.google.com/store/apps/details?id=uk.co.disciplemedia.doctortro&hl=en_US&gl=US Learn more: https://toward.health/community/